News
post
€990k EUREKA grant with Telix Pharmaceuticals
Atley Solutions & Telix Pharmaceuticals are the co-recipients of a €990k grant from the EUREKA Association to demonstrate the potential utility of Astatine-based Targeted Alpha Therapies.
